| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemosiderosis | D006486 | 1 associated lipids |
| Rickets, Hypophosphatemic | D063730 | 1 associated lipids |
| Calcium Metabolism Disorders | D002128 | 1 associated lipids |
| Anemia, Neonatal | D000751 | 1 associated lipids |
| Neurocysticercosis | D020019 | 1 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rowlands M et al. | The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial. | 2013 | Trials | pmid:24015990 |
| Abdel-Razeq H et al. | Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study. | 2013 | Drug Des Devel Ther | pmid:24039403 |
| Kalaivani K | Use of intravenous iron sucrose for treatment of anaemia in pregnancy. | 2013 | Indian J. Med. Res. | pmid:24056552 |
| Kriplani A et al. | Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. | 2013 | Indian J. Med. Res. | pmid:24056559 |
| Palmer K et al. | Review of available intravenous iron preparations in hemodialysis. | 2013 Apr-Jun | CANNT J | pmid:24069699 |
| Michigami T | [Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia]. | 2013 | Clin Calcium | pmid:24076640 |
| pmid:24081613 | ||||
| pmid:24087940 | ||||
| Athibovonsuk P et al. | Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. | 2013 | Gynecol. Oncol. | pmid:24099839 |
| Guzelian PS | Clinical evaluation of liver structure and function in humans exposed to halogenated hydrocarbons. | 1985 | Environ. Health Perspect. | pmid:2411535 |
| Ferumoxytol: an intravenous iron, riskier than iron sucrose. | 2013 | Prescrire Int | pmid:24171212 | |
| Lu QY et al. | Overestimation of flavonoid aglycones as a result of the ex vivo deconjugation of glucuronides by the tissue β-glucuronidase. | 2014 | J Pharm Biomed Anal | pmid:24176739 |
| pmid:24219061 | ||||
| Toyokuni S | Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. | 2014 | Redox Rep. | pmid:24257681 |
| Sasaki Y et al. | Hepcidin production in response to iron is controlled by monocyte-derived humoral factors. | 2014 | Int. J. Hematol. | pmid:24293278 |
| pmid:24333274 | ||||
| Soufras GD et al. | Fatal anaphylactic reaction to iron sucrose in pregnancy: iron-induced Kounis syndrome? | 2013 Nov-Dec | Indian J Pharmacol | pmid:24347784 |
| Italia K et al. | Hydroxyurea could be a good clinically relevant iron chelator. | 2013 | PLoS ONE | pmid:24349400 |
| Balling A et al. | [Chronic hemorrhagic iron deficiency. Sources of hemorrhage, blood loss and systematic iron substitution]. | 1987 | Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. | pmid:2440780 |
| Perelló MF et al. | Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. | 2014 | BJOG | pmid:24423186 |
| Shah RB et al. | Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose. | 2014 | Int J Pharm | pmid:24440404 |
| Macdougall IC et al. | A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. | 2014 | Clin J Am Soc Nephrol | pmid:24458078 |
| pmid:24535226 | ||||
| pmid:24566860 | ||||
| pmid:24588937 | ||||
| pmid:24611780 | ||||
| Hetzel D et al. | A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. | 2014 | Am. J. Hematol. | pmid:24639149 |
| Wagner G and Hollmann S | Uronic acid dehydrogenase from Pseudomonas syringae. Purification and properties. | 1976 | Eur. J. Biochem. | pmid:2471 |
| Kuo KL et al. | Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. | 2014 | J. Am. Soc. Nephrol. | pmid:24722448 |
| pmid:24725852 | ||||
| pmid:24765889 | ||||
| Oredipe OA et al. | Chemopreventative activity of dietary glucarate on azoxymethane-induced altered hepatic foci in rats. | 1989 | Res. Commun. Chem. Pathol. Pharmacol. | pmid:2479062 |
| Tiwari P and Gupta KP | Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents. | 2014 | Toxicol. Appl. Pharmacol. | pmid:24792773 |
| Florey L | The uptake of particulate matter by endothelial cells. | 1967 | Proc. R. Soc. Lond., B, Biol. Sci. | pmid:24796034 |
| Pieracci FM et al. | A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. | 2014 | Crit. Care Med. | pmid:24797376 |
| pmid:24816781 | ||||
| Ferioli A et al. | Alteration of steroid hormone sulfation and D-glucaric acid excretion in lead workers. | 1989 Jul-Sep | Biol Trace Elem Res | pmid:2484601 |
| pmid:24972288 | ||||
| pmid:25036548 | ||||
| pmid:25050519 | ||||
| Price E et al. | A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. | 2014 | Blood Cells Mol. Dis. | pmid:25065855 |
| Dwivedi C et al. | Modulation of chemically initiated and promoted skin tumorigenesis in CD-1 mice by dietary glucarate. | 1989 May-Jun | J. Environ. Pathol. Toxicol. Oncol. | pmid:2509679 |
| pmid:25123238 | ||||
| Corwin HL and Napolitano LM | Anemia in the critically ill: do we need to live with it?*. | 2014 | Crit. Care Med. | pmid:25126804 |
| Beguin Y and Jaspers A | Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. | 2014 | Expert Opin Pharmacother | pmid:25186219 |
| Shiue E et al. | Improving product yields on D-glucose in Escherichia coli via knockout of pgi and zwf and feeding of supplemental carbon sources. | 2015 | Biotechnol. Bioeng. | pmid:25258165 |
| Abou-Issa H et al. | Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model. | 1989 | J. Natl. Cancer Inst. | pmid:2531231 |
| pmid:25315985 | ||||
| pmid:25326244 | ||||
| pmid:25381611 | ||||
| Raman S et al. | Evolution-guided optimization of biosynthetic pathways. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:25453111 |
| Tiwari P et al. | Combinatorial chemopreventive effect of butyric acid, nicotinamide and calcium glucarate against the 7,12-dimethylbenz(a)anthracene induced mouse skin tumorigenesis attained by enhancing the induction of intrinsic apoptotic events. | 2015 | Chem. Biol. Interact. | pmid:25478867 |
| pmid:25514744 | ||||
| pmid:25514745 | ||||
| Almilaji A et al. | Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein. | 2014 | Kidney Blood Press. Res. | pmid:25571875 |
| pmid:25609135 | ||||
| Franco G | Occupational exposure to anaesthetics: liver injury, microsomal enzyme induction and preventive aspects. | 1989 | G Ital Med Lav | pmid:2562737 |
| Frezza M et al. | Abnormal serum gamma-glutamyltranspeptidase in alcoholics. Clues to its explanation. | 1989 | Neth J Med | pmid:2563572 |
| Toblli JE et al. | Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. | 2015 | Heart Lung Circ | pmid:25666998 |
| pmid:25698609 | ||||
| Freche JP et al. | [Variation in the urinary excretion of 6-beta-hydroxycortisol in humans after administration of the new isoquinoline derivative, PK-11195 (52028 RP)]. | 1989 Sep-Oct | Therapie | pmid:2573163 |
| pmid:25754747 | ||||
| Coddington KA et al. | Enterohepatic circulation of T-2 toxin metabolites in the rat. | 1989 Nov-Dec | Drug Metab. Dispos. | pmid:2575494 |
| Dai P et al. | Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. | 2015 | AAPS J | pmid:25762448 |
| Pasquini R et al. | Thioethers, mutagens, and D-glucaric acid in urine of operating room personnel exposed to anesthetics. | 1989 | Teratog., Carcinog. Mutagen. | pmid:2576815 |
| pmid:25802012 | ||||
| pmid:25824489 | ||||
| Toblli JE et al. | Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. | 2015 | Int. J. Cardiol. | pmid:25838213 |
| pmid:25890861 | ||||
| pmid:25906050 | ||||
| Kitasato I et al. | Effect of glucarolactam on low-dose nephrotoxicities of dibekacin and gentamicin in Fischer rats. | 1989 | Drugs Exp Clin Res | pmid:2591297 |
| Yokota M et al. | Effect of glucarolactam on ototoxicity of aminoglycoside antibiotics in guinea-pigs. | 1989 | Drugs Exp Clin Res | pmid:2591298 |
| Bhandari S et al. | A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. | 2015 | Nephrol. Dial. Transplant. | pmid:25925701 |
| Horváth T et al. | Drug metabolism in drug-induced liver diseases: pathogenetic role of active metabolites. | 1989 | Acta Physiol Hung | pmid:2596319 |
| Connor JR et al. | Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. | 2015 | PLoS ONE | pmid:25973894 |
| pmid:26031262 | ||||
| Agarwal R et al. | A randomized trial of intravenous and oral iron in chronic kidney disease. | 2015 | Kidney Int. | pmid:26083656 |
| pmid:26118386 | ||||
| pmid:26149838 | ||||
| pmid:26168105 | ||||
| Ren X et al. | Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study. | 2015 | Med. Sci. Monit. | pmid:26175087 |
| Minami D et al. | Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model. | 2015 | Cancer Sci. | pmid:26211743 |
| Airy M et al. | Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. | 2015 | Nephrol. Dial. Transplant. | pmid:26311216 |
| pmid:26385819 | ||||
| pmid:26422625 | ||||
| pmid:26526024 | ||||
| pmid:26575062 | ||||
| pmid:26605680 | ||||
| pmid:26637994 | ||||
| Mori M et al. | Urinary and biliary metabolites of mephentermine in male Wistar rats. | 1989 | Xenobiotica | pmid:2665325 |
| Tiwari P et al. | Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs. | 2016 | Biochimie | pmid:26655363 |
| pmid:26657161 | ||||
| Bitsi S et al. | Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:26670484 |
| pmid:26686338 | ||||
| pmid:26749401 | ||||
| pmid:26796581 | ||||
| Lee T et al. | Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. | 2017 | Gut | pmid:26848182 |
| pmid:26868063 | ||||
| pmid:26901550 | ||||
| pmid:26934422 |